The Impact of Direct Healthcare Professional Communication on Prescribing Practice in the UK Hospital Setting: An Interrupted Time Series Analysis

Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors

(2013) Wayne A. Ray   ANNALS OF INTERNAL MEDICINE

Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use

(2013) Mette Charlot   ANNALS OF INTERNAL MEDICINE

Impact of Safety-Related Regulatory Action on Drug Use in Ambulatory Care in the Netherlands

(2012) S Piening et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals

(2012) Rikje Ruiter et al.   DRUG SAFETY

Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors

(2012) Stacie B. Dusetzina et al.   MEDICAL CARE

Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study

(2012) Eduardo Carracedo-Martínez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs

(2012) I. J. Douglas et al.   BMJ-British Medical Journal

Trends in Antipsychotic Use in Dementia 1999-2007

(2011) Helen C. Kales et al.   ARCHIVES OF GENERAL PSYCHIATRY

An assessment of the quality and impact of NPSA medication safety outputs issued to the NHS in England and Wales

(2011) A. Lankshear et al.   BMJ Quality & Safety

Impact of FDA Black Box Advisory on Antipsychotic Medication Use

(2010) E. Ray Dorsey   ARCHIVES OF INTERNAL MEDICINE

Pantoprazole Does Not Influence the Antiplatelet Effect of Clopidogrel-A Whole Blood Aggregometry Study After Coronary Stenting

(2010) Horst Neubauer et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation

(2010) Rudolf Jarai et al.   THROMBOSIS AND HAEMOSTASIS

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

(2009) D. N. Juurlink et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome

(2009) Jeremy A. Rassen et al.   CIRCULATION

Upper Gastrointestinal Bleeding in Patients Receiving Dual Antiplatelet Therapy after Coronary Stenting

(2009) Hiroshi Yasuda et al.   INTERNAL MEDICINE

Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome

(2009) P. Michael Ho   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

(2009) Michelle L O'Donoghue et al.   LANCET

Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy

(2009) Christine S. Zuern et al.   THROMBOSIS RESEARCH

Initial Assessment of Clinical Impact of a Drug Interaction Between Clopidogrel and Proton Pump Inhibitors

(2008) Edmund Pezalla et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

(2008) Martine Gilard et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY